Biome Lift Clinical Trial Hits Recruitment Target
Filed with ASX · · 4 pages · English
Watch Biome Australia's latest callBiome Australia (ASX:BIO) Q1 2026 Earnings Call · Replay · Oct 22, 2025Read the transcript of Biome Australia (ASX:BIO) Q1 2026 Earnings Call● Biome Lift Probiotic is being investigated for its ability to reduce the severity of symptoms in subthreshold depression vs placebo ● Preliminary results are expected in Q3 FY23 company’) is pleased to announce that recruitment for the Biome Lift Probiotic clinical trial (the “trial”) taking place at La Trobe University in Melbourne has surpassed the sample size calculation target of 40 particip
Earlier from Biome Australia
- Delivery of Activated Probiotics to 370 Priceline Pharmacies
- FY22 Revenue Guidance
- Biome signs distribution agreement with Priceline Pharmacy
- FY22 Trading Update
- Record H1 sales deliver 98% revenue growth
Later from Biome Australia
- FY23 Trading Update
- FY22 Company Presentation
- FY23 Q1 Sales Revenue Update and FY23 Forecast
- Biome records record H1 sales revenue
- Biome H1 FY23 Investor Presentation
Follow Biome Australia into a list and get an email when it puts out news.
Follow Biome Australia